Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

about

Evaluation of the novel ultrasound score for large joints in psoriatic arthritis and ankylosing spondylitis: six month experience in daily clinical practice Inflammation-sleep interface in brain disease: TNF, insulin, orexin

P2860

Q35071432-66A0B94C-10E2-4AC3-BD63-000BBDED5DB0 Q37714770-0F5F46FA-3C7A-4D5A-930D-59FD9AB538BF

P2860

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

Item

http://www.wikidata.org/entity/Q35687019

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@ast

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@en

type

Item

label

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@ast

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@en

prefLabel

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@ast

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@en

P1476

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

@en

P2093

Dominique Baeten

http://www.w3.org/2001/XMLSchema#string

Jacqueline E Paramarta

http://www.w3.org/2001/XMLSchema#string

Leen De Rycke

http://www.w3.org/2001/XMLSchema#string

P2860

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Certolizumab pegol for the treatment of Crohn's disease

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

Monitoring the T-cell receptor repertoire at single-clone resolution.

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.

P304

127-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874312901105010127

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221779544

http://www.w3.org/2001/XMLSchema#string

P698

22279512

http://www.w3.org/2001/XMLSchema#string

P932

3263444

http://www.w3.org/2001/XMLSchema#string

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

about

P2860

P2860

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932